USA: Researchers have discovered in a new research that compared with angiotensin II–inhibiting antihypertensives, angiotensin II–stimulating medications were associated with a lower risk of certain ...

Antihypertensives that stimulate angiotensin II receptors are associated with a lower risk for biomarkers of dementia.

Role of the RAAS in the Pathophysiology of Heart Failure ACE inhibitors have no effect on angiotensin II formed by alternate pathways. In contrast, ARBs would be expected to inhibit the biologic ...

Researchers have long known that the peptide angiotensin II is central to blood pressure control—but there is yet more to learn. A new study shows how angiotensin II cooperates with the JAK2 kinase, ...

Despite the availability of effective antihypertensive therapies, global blood pressure control rates remain unacceptably low. Contributing factors, such as low treatment adherence, therapeutic ...

Daniel Leisman, MD, a resident in the Department of Medicine at Massachusetts General Hospital, is the lead author of a new study in the Proceedings of the National Academy of Sciences (PNAS) titled ...

Cardiovascular illnesses, such as high blood pressure and heart problems, are often treated with angiotensin-converting enzyme (ACE) inhibitors. The ACE inhibitors lower blood pressure by relaxing ...

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are antihypertensive medicines used to treat high blood pressure. While the enzyme inhibitors work by reducing the level of ...

We present a case of new-onset collapsing focal segmental glomerulosclerosis and antibody-mediated rejection that occurred 1 month after kidney transplantation in association with AT1-receptor ...

Vasodilatory shock is a life-threatening syndrome that requires immediate treatment; conventional vasopressors have a narrow therapeutic window and toxicities at high doses. New research findings are ...